Skip to main content
Clinical Trials/NCT03106233
NCT03106233
Completed
Not Applicable

The Lateral Thigh Perforator (LTP) Flap for Autologous Breast Reconstruction: A Prospective Analysis of 138 Flaps

Maastricht University Medical Center1 site in 1 country86 target enrollmentSeptember 2012
ConditionsBreast Cancer

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Breast Cancer
Sponsor
Maastricht University Medical Center
Enrollment
86
Locations
1
Primary Endpoint
Recipient- and donor-site complications
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

The lateral thigh perforator (LTP) flap was previously introduced as an alternative flap for autologous breast reconstruction when the abdomen is not suitable as a donor site. In this prospective study all LTP flap breast reconstructions that have been performed since September 2012 are analyzed. In addition, the surgical refinements that were introduced over the years are reported.

Registry
clinicaltrials.gov
Start Date
September 2012
End Date
December 2016
Last Updated
9 years ago
Study Type
Observational
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Rene van der Hulst

Prof. dr.

Maastricht University Medical Center

Eligibility Criteria

Inclusion Criteria

  • Lateral thigh region suitable as a donor site
  • Abdomen not suitable as donor site
  • Informed consent

Exclusion Criteria

  • Pre-operative imaging showing no suitable perforators

Outcomes

Primary Outcomes

Recipient- and donor-site complications

Time Frame: Through study completion up to an average of 12 months post-operatively

Recipient site: Total flap loss, partial flap loss, venous congestion, infection, hematoma, seroma, fat necrosis and wound complications. Donor site: Infection, hematoma, seroma, fat necrosis, wound complications.

Secondary Outcomes

  • Flap re-explorations(Through study completion up to an average of 12 months post-operatively)

Study Sites (1)

Loading locations...

Similar Trials